Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Mesa Laboratories (MLAB) EBIAT (2016 - 2025)

Mesa Laboratories' EBIAT history spans 16 years, with the latest figure at $3.6 million for Q4 2025.

  • For Q4 2025, EBIAT rose 316.59% year-over-year to $3.6 million; the TTM value through Dec 2025 reached $11.7 million, up 104.31%, while the annual FY2025 figure was $6.0 million, 102.16% up from the prior year.
  • EBIAT for Q4 2025 was $3.6 million at Mesa Laboratories, up from $2.5 million in the prior quarter.
  • Across five years, EBIAT topped out at $4.7 million in Q2 2025 and bottomed at -$276.0 million in Q1 2024.
  • The 5-year median for EBIAT is $1.1 million (2022), against an average of -$12.7 million.
  • The largest YoY upside for EBIAT was 717.12% in 2024 against a maximum downside of 38880.93% in 2024.
  • A 5-year view of EBIAT shows it stood at -$2.1 million in 2021, then skyrocketed by 121.89% to $451000.0 in 2022, then soared by 369.18% to $2.1 million in 2023, then tumbled by 179.21% to -$1.7 million in 2024, then surged by 316.59% to $3.6 million in 2025.
  • Per Business Quant, the three most recent readings for MLAB's EBIAT are $3.6 million (Q4 2025), $2.5 million (Q3 2025), and $4.7 million (Q2 2025).